Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

Open source

DOI: 10.1016/s0140-6736(12)61084-8
Published: 2012 Dec 1
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-12-61084-8,
  title = {Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.},
  author = {Laharie D and Bourreille A and Branche J and Allez M and Bouhnik Y and Filippi J and Zerbib F and Savoye G and Nachury M and Moreau J and Delchier JC and Cosnes J and Ricart E and Dewit O and Lopez-Sanroman A and Dupas JL and Carbonnel F and Bommelaer G and Coffin B and Roblin X and Van Assche G and Esteve M and Färkkilä M and Gisbert JP and Marteau P and Nahon S and de Vos M and Franchimont D and Mary JY and Colombel JF and Lémann M and Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives},
  year = {2012},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(12)61084-8},
  url = {https://doi.org/10.1016/s0140-6736(12)61084-8}
}

RIS

TY  - JOUR
TI  - Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
AU  - Laharie D
AU  - Bourreille A
AU  - Branche J
AU  - Allez M
AU  - Bouhnik Y
AU  - Filippi J
AU  - Zerbib F
AU  - Savoye G
AU  - Nachury M
AU  - Moreau J
AU  - Delchier JC
AU  - Cosnes J
AU  - Ricart E
AU  - Dewit O
AU  - Lopez-Sanroman A
AU  - Dupas JL
AU  - Carbonnel F
AU  - Bommelaer G
AU  - Coffin B
AU  - Roblin X
AU  - Van Assche G
AU  - Esteve M
AU  - Färkkilä M
AU  - Gisbert JP
AU  - Marteau P
AU  - Nahon S
AU  - de Vos M
AU  - Franchimont D
AU  - Mary JY
AU  - Colombel JF
AU  - Lémann M
AU  - Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives
PY  - 2012
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(12)61084-8
UR  - https://doi.org/10.1016/s0140-6736(12)61084-8
ER  -

APA

D, L., A, B., J, B., M, A., Y, B., J, F., F, Z., G, S., M, N., J, M., JC, D., J, C., E, R., O, D., A, L., JL, D., F, C., G, B., B, C., X, R., G, V. A., M, E., M, F., JP, G., P, M., S, N., M, D. V., D, F., JY, M., JF, C., M, L., & Digestives, G. D. T. D. A. I. (2012). Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(12)61084-8

Source records

pubmed · retrieved 2026-09-26T15:18:25.407Z